| Identification | Back Directory | [Name]
1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- | [CAS]
2648403-17-0 | [Synonyms]
THR-β agonist 1
1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- | [Molecular Formula]
C17H14Cl2FN5O4 | [MOL File]
2648403-17-0.mol | [Molecular Weight]
442.23 |
| Hazard Information | Back Directory | [Uses]
THR-β Agonist 1 is a potent and selective agonist of THRβ. Thyroid hormone receptor mediates the physiological activity of thyroid hormones which plays a key role in normal growth and development of the body and in maintaining metabolic balance. THR-β Agonist 1 has the potential for the research of thyroid hormone receptor-related diseases (extracted from patent WO2021104288A1, compound 2)[1]. | [References]
[1] Hejun lv, et al. 1,2,4-triazine-3,5-dione compound and its preparation method and application. Patent WO2021104288A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|